Amdipharm Mercury launches £985m loan
UK pharmaceuticals group Amdipharm Mercury, owned by Cinven, has launched a £985m-equivalent loan that will refinance debt and recapitalise its senior debt structure.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: